Clinical research
On Monday, Sarepta Therapeutics announced positive results from a small study of SRP-9003, its gene therapy for limb-girdle muscular dystrophy Type 2E (LGMD2E).
The results of Lumasiran were presented at the European Renal Association-European Dialysis and Transplant Association International Congress.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 8, 2020.
Roxadustat was non-inferior to Aranesp in hemoglobin levels during the first 24 weeks of treatment, which was the trial’s primary endpoint.
As summer begins, we’re seeing a shift away from COVID-19-related news and a stronger output of other clinical trial news. Here’s a look.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 5, 2020.
Check out this article for the impacts that Biotech Bay companies are experiencing due to COVID-19.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 4, 2020.
Imago BioSciences will announce preliminary results from its Phase IIb clinical trial for myelofibrosis (MF) at the 25th European Hematology Association (EHA) Annual Congress that begins June 12, 2020.
The company announced its Covance drug development business was launching COVID-19 Clinical Trial Connect in the U.S. to help people find information on taking part in clinical trials related to COVID-19.
PRESS RELEASES